West Nile Virus Seroconversion in Penguins After Vaccination with a Killed Virus Vaccine or a DNA Vaccine
Authors:
- Michelle R. DavisMDMichelle R. Davis
- Jennifer N. LanganJLJennifer N. Langan
- Yvette J. JohnsonYJYvette J. Johnson
- Branson W. RitchieBRBranson W. Ritchie
- William Van BonnWBWilliam Van Bonn
- 1 December 2008
- journal article
- Published by American Association of Zoo Veterinarians in Journal of Zoo and Wildlife Medicine
- Vol. 39 (4) , 582-589
Abstract
To investigate the serologic response of penguins to West Nile virus (WNV) vaccines, four species of exclusively indoor-housed penguins, negative for WNV by serology, were evaluated: Humboldt (Spheniscus humboldti), Magellanic (Spheniscus magellanicus), Gentoo (Pygoscelis papua), and Rockhopper (Eudyptes chrysoscome) penguins. Birds were inoculated with either a killed virus vaccine or a plasmid-mediated DNA WNV vaccine, and postinoculation serology was evaluated. Both vaccines induced seroconversion in all four species, and no adverse reactions were noted. Postvaccination serology results varied across species and vaccine types. However, in all four species, the killed virus vaccine resulted in a greater seroconversion rate than the DNA vaccine and in a significantly shorter time period. Additionally, the duration of the seropositive titer was significantly longer in those birds vaccinated with the killed virus vaccine compared with those vaccinated with the DNA vaccine. A subset of unvaccinated penguins serving as negative controls remained negative throughout the duration of the study despite the presence of WNV in the geographic locations of the study, suggesting that indoor housing may minimize exposure to the virus and may be an additional means of preventing WNV infection in penguins.Keywords
This publication has 38 references indexed in Scilit:
- A functional genomics approach to the study of avian innate immunityCytogenetic and Genome Research, 2007
- Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infectionEuropean Journal of Immunology, 2007
- Antigen‐specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitisEuropean Journal of Immunology, 2007
- Lack of Detectable Antibody Response in Greater Flamingos (Phoenicopterus ruber ruber) After Vaccination Against West Nile Virus With a Killed Equine VaccineJournal of Avian Medicine and Surgery, 2006
- Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMiceJournal of Virology, 2003
- Absence of Humoral Response in Flamingos and Red-Tailed Hawks to Experimental Vaccination with a Killed West Nile Virus VaccineAvian Diseases, 2003
- Induction of Potent Th1‐Type Immune Responses from a Novel DNA Vaccine for West Nile Virus New York Isolate (WNV‐NY1999)The Journal of Infectious Diseases, 2001
- The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vectorGene Therapy, 1999
- CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.Journal of Clinical Investigation, 1998
- DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boostVaccine, 1996